Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated Steatohepatitis [0.03%]
Juan Frias,Robert Schmouder,Eric Lawitz et al.
Juan Frias et al.
Background: Drug combinations have potential for additive or synergistic efficacy in patients with metabolic dysfunction-associated steatohepatitis (MASH). ...
Review article: Seeing Is Believing-The Eosinophilic Oesophagitis Endoscopic Reference Score Can Serve as a Valuable Clinical Trial Endpoint in Eosinophilic Oesophagitis [0.03%]
述评：眼见为实-嗜酸性粒细胞柱状食管炎内镜参考评分可作为嗜酸性粒细胞柱状食管炎临床试验的重要观察指标
Ikuo Hirano,Glenn T Furuta,Gary W Falk et al.
Ikuo Hirano et al.
Background: Eosinophilic oesophagitis (EoE) is a major contributor to upper gastrointestinal morbidity. Although an increasing number of treatment modalities have been developed, most are assessed by symptoms and the hist...
Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis' [0.03%]
论著《自身免疫性肝炎患者门脉高压的特点及其预后价值》
Marlene Padilla-Lopez,María Carlota Londoño,Pinelopi Arvaniti
Marlene Padilla-Lopez
Letter on 'Clinical Trial: Effect of a 28-Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis (EndoFOD)-A Randomised, Controlled Crossover Feeding Study' [0.03%]
关于“临床试验：为期28天的低FODMAP饮食对子宫内膜异位症相关胃肠症状的影响（EndoFOD）-一项随机对照交叉喂养研究”的信件
Wancheng Zhao,Lei Yu,Jiao Wang
Wancheng Zhao
Letter: Reinterpreting the Role of Microbiota-Driven Nitric Oxide in Cirrhotic Portal Hypertension-A Maladaptive Compensatory Response? [0.03%]
来信：肠道微生物群诱导的一氧化氮在门脉高压发病机制中扮演适应性抑或失代偿角色？
Meiyu Yang,Tiantian Zhang,Susu Zhang
Meiyu Yang
Letter: Safety and Methodological Considerations for Hepatitis B Immunoglobulin Withdrawal in Hepatitis B Virus Mono-Infected Liver Transplant Recipients [0.03%]
来信：单种乙肝病毒受者肝脏移植受者的乙肝免疫球蛋白撤药的安全及方法学考虑因素
Wenying Huang,Wen Zhang,Chang Hu
Wenying Huang
Editorial: An Important Step Towards Mastering Metabolic Dysfunction-Associated Steatohepatitis-Targeted Therapy in Diabetes [0.03%]
述评·重要一步：迈向糖尿病代谢功能障碍相关肝硬化治疗_masterorfather
Johnny Yau-Cheung Chang,Chi-Ho Lee
Johnny Yau-Cheung Chang
Editorial: Shingles Risk in IBD-More Evidence to Support Routine Preventive Vaccination? [0.03%]
编辑部：炎症性肠病的带状疱疹风险——支持常规预防接种的更多证据吗？
Keith Bodger
Keith Bodger
Letter: Affirming Cardiac Safety While Highlighting Areas for Further Research [0.03%]
致编辑函：确认心脏安全的同时指出进一步研究的领域
Shanshan Huang,Jie Zhou
Shanshan Huang